Host intestinal mucosa and immune system

The host intestinal mucosa and immune system constitute a sophisticated biological network designed to manage the body's largest interface with the external environment. This system includes the physical epithelial barrier, a protective mucus layer, and the gut-associated lymphoid tissue (GALT), which houses a significant portion of the body's total immune cell population (Source: Nature Reviews Immunology). Its primary role is to maintain oral tolerance toward harmless food antigens and commensal bacteria while remaining vigilant against enteric pathogens (Source: NIH). When the balance of this system is disrupted, it leads to chronic inflammatory states such as Inflammatory Bowel Disease (IBD), characterized by mucosal damage and aberrant immune activation (Source: Lancet). Pharmacological strategies targeting this system often focus on specific molecular mediators like tumor necrosis factor (TNF) or integrins to reduce inflammation and promote mucosal healing (Source: Gastroenterology & Hepatology).

Other names

Gut-associated lymphoid tissueGALTIntestinal mucosal barrierGastrointestinal immune systemIntestinal immune microenvironment

Drugs acting within this system typically function through the inhibition of pro-inflammatory cytokines (e.g., TNF-alpha, IL-12/23), blockade of leukocyte trafficking to the gut (e.g., integrin antagonism), or broad suppression of immune cell proliferation and activity (Source: PubMed).